EXPERIMENTAL DRUG LOOKS TO BE GASTRIC BYPASS SURGERY IN PILL FORM

Summary from the TLDR newsletter

The popularity of GLP-1 drugs for weight loss has led to companies competing to make new and improved anti-obesity medications. Boston-based Syntis Bio has created a daily pill that mimics the effects of gastric bypass without actual surgery. The drug is designed to redirect the absorption of nutrients from the beginning of the small intestine to its end, changing how the body absorbs food and leaving people feeling fuller from eating less. Early data from animals and a small group of humans shows that the pill is safe and may be able to suppress hunger.